Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 12Recruiting 5Not yet recruiting 4Withdrawn 2Unknown 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Head & Neck 3

Conditions

Breast Neoplasms 544Neoplasms 384Carcinoma, Non-Small-Cell Lung 325Colorectal Neoplasms 296Lung Neoplasms 237Prostatic Neoplasms 220Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Leukemia, Myeloid, Acute 141Uterine Cervical Neoplasms 132Multiple Myeloma 130Recurrence 120Rectal Neoplasms 114Ovarian Neoplasms 109Neoplasm Metastasis 105Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 91Triple Negative Breast Neoplasms 87Esophageal Neoplasms 84Glioblastoma 82Endometrial Neoplasms 80Small Cell Lung Carcinoma 79Brain Neoplasms 79Colonic Neoplasms 78Melanoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Glioma 63Disease 60

Interventions

Audiometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Ototoxicity × Clear all
NCT07622407 2026-06-03

TIMELY REHAB

VA Office of Research and Development

Phase NA Not yet recruiting
74 enrolled
Head & Neck

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting
500 enrolled

Ototoxicity, Neoplasms

NCT06929468 2025-04-16

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Paracelsus Medical University

Not yet recruiting
55 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT05946577 2023-07-14

AURACCO

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
140 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Head and Neck Neoplasms, Salivary Gland Neoplasms, Tinnitus, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡